Treatment of neurological conditions using complement C5a receptor modulators

Details for Australian Patent Application No. 2005226792 (hide)

Owner Promics Pty Limited

Inventors Taylor, Stephen Maxwell; Woodruff, Trent Martin

Agent Blake Dawson Waldron Patent Services

Pub. Number AU-A-2005226792

PCT Pub. Number WO2005/092366

Priority 2004901652 26.03.04 AU

Filing date 21 March 2005

Wipo publication date 6 October 2005

International Classifications

A61K 38/12 (2006.01) Medicinal preparations containing peptides - Cyclic peptides

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/092366 Priority application(s): WO2005/092366

28 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005226795-Spinal and upper cervical impulse treatment device

2005226786-Novel cyclopentenedione antifungal compounds and methods for their use